HB4783 - Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

      H.B. No. 4783         AN ACT   relating to a report on governmental opioid antagonist programs to   reverse and prevent opioid overdoses.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Subchapter B, Chapter 461A, Health and Safety   Code, is amended by adding Section 461A.060 to read as follows:           Sec.   461A.060.     BIENNIAL REPORT ON OPIOID ANTAGONIST   PROGRAMS FOR OPIOID OVERDOSE REVERSAL AND PREVENTION.   (a)   In this   section, "opioid antagonist" has the meaning assigned by Section   483.101.           (b)     Not later than October 1 of each even-numbered year, the   commission shall:                 (1)     prepare a report evaluating the distribution of   opioid antagonists in this state to reverse and prevent opioid   overdoses; and                 (2)     submit the report to the governor, the lieutenant   governor, and the speaker of the house of representatives.           (c)  The report described by Subsection (b) must:                 (1)     include a needs assessment for the opioid   antagonist programs established by state agencies and institutions   of higher education;                 (2)     establish a statewide saturation goal for opioid   antagonists and include:                       (A)     a description of the data sources and   methodology used to estimate insufficiencies in the current supply   of opioid antagonists; and                       (B)     a communications plan to address opioid   overdoses in areas of this state at higher risk for increased   numbers of overdoses;                 (3)     include a description of all state and federal   money appropriated to governmental opioid antagonist programs;                 (4)     establish opioid antagonist distribution   strategies for this state;                 (5)     list and describe all available state and   federally funded purchase and distribution programs for opioid   antagonists; and                 (6)     recommend improvements for addressing opioid   overdoses among high-risk populations, including school-aged   children, pregnant and postpartum women, and individuals residing   in rural areas of this state.           (d)     In preparing the report under this section, the   commission shall coordinate and consult with each state agency and   institution of higher education that receives funding or other   resources for the distribution of opioid antagonists.          SECTION 2.  This Act takes effect September 1, 2025.       ______________________________ ______________________________      President of the Senate Speaker of the House                   I certify that H.B. No. 4783 was passed by the House on May 6,   2025, by the following vote:  Yeas 137, Nays 10, 1 present, not   voting; and that the House concurred in Senate amendments to H.B.   No. 4783 on May 23, 2025, by the following vote:  Yeas 112, Nays 24,   1 present, not voting.     ______________________________   Chief Clerk of the House               I certify that H.B. No. 4783 was passed by the Senate, with   amendments, on May 20, 2025, by the following vote:  Yeas 30, Nays   1.     ______________________________   Secretary of the Senate      APPROVED: __________________                   Date                       __________________                 Governor